» Articles » PMID: 36371595

Hepatic HRC Induces Hepatocyte Pyroptosis and HSCs Activation Via NLRP3/caspase-1 Pathway

Overview
Specialty General Medicine
Date 2022 Nov 13
PMID 36371595
Authors
Affiliations
Soon will be listed here.
Abstract

The histidine-rich calcium-binding protein (HRC) is a regulator of Ca2 + homeostasis and it plays a significant role in liver fibrosis. Pyroptosis, a specific inflammatory cell death, can lead to hepatic stellate cells (HSCs) activation and liver fibrosis. However, the role of HRC in pyroptosis has not been explored. In this study, we demonstrated that HRC, mainly located in the hepatocyte, was over expressed in fibrotic liver tissues. We further found that enforced expression of HRC in hepatocytes induced pyroptosis and HMGB1 release, and subsequently led to HSCs activation by NLRP3/caspase-1 pathway. In addition, the proliferation and migration of HSCs were also enhanced by HRC overexpression in hepatocytes. Furthermore, NLRP3 inhibitor MCC950 and caspase-1 inhibitor VX-765 alleviated hepatic HRC-mediated hepatocytes pyroptosis and HSCs activation. This study demonstrated that hepatic HRC promoted HSCs activation by inducing hepatocyte pyroptosis, which suggests that HRC may be a promising therapeutic target to prevent liver fibrosis.

Citing Articles

Pyroptosis in health and disease: mechanisms, regulation and clinical perspective.

Liu Y, Pan R, Ouyang Y, Gu W, Xiao T, Yang H Signal Transduct Target Ther. 2024; 9(1):245.

PMID: 39300122 PMC: 11413206. DOI: 10.1038/s41392-024-01958-2.


Mechanism of sodium butyrate, a metabolite of gut microbiota, regulating cardiac fibroblast transdifferentiation via the NLRP3/Caspase-1 pyroptosis pathway.

Dong T, Huang D, Jin Z J Cardiothorac Surg. 2024; 19(1):208.

PMID: 38616256 PMC: 11017590. DOI: 10.1186/s13019-024-02692-0.


Programmed Cell Death in Liver Fibrosis.

Gao R, Tang H, Mao J J Inflamm Res. 2023; 16:3897-3910.

PMID: 37674533 PMC: 10478980. DOI: 10.2147/JIR.S427868.

References
1.
Asrani S, Devarbhavi H, Eaton J, Kamath P . Burden of liver diseases in the world. J Hepatol. 2018; 70(1):151-171. DOI: 10.1016/j.jhep.2018.09.014. View

2.
Seki E, Schwabe R . Hepatic inflammation and fibrosis: functional links and key pathways. Hepatology. 2014; 61(3):1066-79. PMC: 4306641. DOI: 10.1002/hep.27332. View

3.
Marrone G, Shah V, Gracia-Sancho J . Sinusoidal communication in liver fibrosis and regeneration. J Hepatol. 2016; 65(3):608-17. PMC: 4992446. DOI: 10.1016/j.jhep.2016.04.018. View

4.
Wree A, Mehal W, Feldstein A . Targeting Cell Death and Sterile Inflammation Loop for the Treatment of Nonalcoholic Steatohepatitis. Semin Liver Dis. 2016; 36(1):27-36. PMC: 4955833. DOI: 10.1055/s-0035-1571272. View

5.
Galluzzi L, Vitale I, Aaronson S, Abrams J, Adam D, Agostinis P . Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018. Cell Death Differ. 2018; 25(3):486-541. PMC: 5864239. DOI: 10.1038/s41418-017-0012-4. View